Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice - Normandie Université Access content directly
Conference Papers Year : 2019

Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice

No file

Dates and versions

hal-02294639 , version 1 (23-09-2019)

Identifiers

  • HAL Id : hal-02294639 , version 1

Cite

Hélène Castel, T Al Sagheer, Martine Dubois, Cynthia Campart, Laurence Desrues, et al.. Impact of hormone-therapy used in CRPC patients: Evaluation of abiraterone acetate/prednisone or enzalutamide on activity and cognitive functions in aged castrated mice. 2019 ASCO annual meeting, May 2019, Chicago, United States. ⟨hal-02294639⟩
29 View
0 Download

Share

Gmail Mastodon Facebook X LinkedIn More